| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 4. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | nepafenac (Nevanac®) |
| Formulation | 3mg/ml eye drops |
| Reference number | 3354 |
| Indication | Prevention and treatment of postoperative pain and inflammation associated with cataract surgery, and reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients |
| Company | Alcon Laboratories (UK) Ltd |
| BNF chapter | Eye |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 23/12/2016 |